Proteomics

Dataset Information

0

Proteomic Analysis insights into Potential Mechanism of SGLT2 Inhibitors cardiovascular benefit in Diabetic cardiomyopathy

ABSTRACT: Diabetic cardiomyopathy (DCM) is one of the major causes of heart failure in diabetic patients, but its pathogenesis remains unclear. Sodium glucose cotransporter 2 inhibitors (SGLT2i) can effectively reduce the risk of cardiovascular death and heart failure in DCM patients, but the underlying mechanism has not been elucidated. We established a DCM rat model followed by treatment with empagliflozin (EMPA) for 12 weeks. The proteomics of the myocardium in the rat model was performed to identify the potential targets and signaling pathways associated with the cardiovascular benefit of SGLT2i.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Rattus Norvegicus (rat)

TISSUE(S): Heart

SUBMITTER: Yangbo Xi  

LAB HEAD: Central Laboratory, Dongguan Binhaiwan Hospital

PROVIDER: PXD036090 | Pride | 2023-03-10

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
HFX6_FZPR210063233-1A.raw Raw
HFX6_FZPR210063234-1A.raw Raw
HFX6_FZPR210063235-1A.raw Raw
HFX6_FZPR210063236-1A.raw Raw
HFX6_FZPR210063237-1A.raw Raw
Items per page:
1 - 5 of 24
altmetric image

Publications

Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy.

Xi Yangbo Y   Chen Dongping D   Dong Zhihui Z   Zhang Jinhua J   Lam Hingcheung H   He Jiading J   Du Keyi K   Chen Can C   Guo Jun J   Xiao Jianmin J  

Frontiers in cardiovascular medicine 20221005

<h4>Background</h4>Metabolic and energy disorders are considered central to the etiology of diabetic cardiomyopathy (DCM). Sodium-glucose cotransporter-2 inhibitors (SGLT2i) can effectively reduce the risk of cardiovascular death and heart failure in patients with DCM. However, the underlying mechanism has not been elucidated.<h4>Methods</h4>We established a DCM rat model followed by treatment with empagliflozin (EMPA) for 12 weeks. Echocardiography, blood tests, histopathology, and transmission  ...[more]

Similar Datasets

Transcriptomics RNA Sequencing of Cardiac in STZ-induced Rat model Uncovers Potential Target of Diabetic cardiomyopathy
2022-03-13 | GSE197999 | GEO
Proteomics Proteomic analysis of ischemic and dilated cardiomyopathy pre-mortem human hearts
2020-05-01 | PXD018678 | Pride
Proteomics Proteomic analysis of donor and cardiomyopathy pre-mortem human hearts
2023-05-18 | PXD014826 | Pride
Transcriptomics USP28 Serves as A Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart [RNA-seq]
2023-10-15 | GSE244904 | GEO
Transcriptomics Expression data from human heart
2013-10-17 | GSE42955 | GEO
Proteomics Major metabolic pathway alterations in the rat myocardium during development of Type 2 diabetes mellitus
2018-06-26 | PXD009538 | Pride
Proteomics Major metabolic pathway alterations in the rat myocardium during development of Type 2 diabetes mellitus, part 2
2018-06-26 | PXD009555 | Pride
Proteomics Major metabolic pathway alterations in the rat myocardium during development of Type 2 diabetes mellitus, part 1
2018-06-26 | PXD009554 | Pride
Proteomics Canagliflozin regulates ferroptosis to ameliorate heart failure in rats with preserved ejection fraction
2022-05-20 | PXD029031 | Pride
Proteomics Mass spectrometry-based redox and protein profiling reveals distinct protein expression and oxidation patterns in failing human hearts
2021-09-09 | PXD021261 | Pride